nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—SLC22A7—Organic anion transport—SLC22A12—nephrolithiasis	0.0485	0.0988	CbGpPWpGaD
Fluorouracil—UPP2—renal system—nephrolithiasis	0.0291	0.0978	CbGeAlD
Fluorouracil—PPAT—Purine metabolism—APRT—nephrolithiasis	0.0283	0.0577	CbGpPWpGaD
Fluorouracil—UPP2—kidney—nephrolithiasis	0.0282	0.0946	CbGeAlD
Fluorouracil—UPP2—cortex of kidney—nephrolithiasis	0.0274	0.0921	CbGeAlD
Fluorouracil—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0226	0.046	CbGpPWpGaD
Fluorouracil—UMPS—Nucleotide metabolism—APRT—nephrolithiasis	0.0221	0.045	CbGpPWpGaD
Fluorouracil—UPP1—Nucleotide metabolism—APRT—nephrolithiasis	0.0205	0.0418	CbGpPWpGaD
Fluorouracil—UPP2—Nucleotide metabolism—APRT—nephrolithiasis	0.0205	0.0418	CbGpPWpGaD
Fluorouracil—UMPS—nephron tubule—nephrolithiasis	0.0182	0.0611	CbGeAlD
Fluorouracil—UPP1—nephron tubule—nephrolithiasis	0.0167	0.056	CbGeAlD
Fluorouracil—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.0157	0.0319	CbGpPWpGaD
Fluorouracil—UMPS—cortex of kidney—nephrolithiasis	0.0156	0.0523	CbGeAlD
Fluorouracil—UPP1—cortex of kidney—nephrolithiasis	0.0143	0.0479	CbGeAlD
Fluorouracil—DPYD—Nucleotide metabolism—APRT—nephrolithiasis	0.0142	0.029	CbGpPWpGaD
Fluorouracil—PPAT—Nucleotide metabolism—APRT—nephrolithiasis	0.0142	0.029	CbGpPWpGaD
Fluorouracil—DPYD—nephron tubule—nephrolithiasis	0.0135	0.0455	CbGeAlD
Fluorouracil—DPYD—cortex of kidney—nephrolithiasis	0.0116	0.0389	CbGeAlD
Fluorouracil—CYP1A2—urine—nephrolithiasis	0.0115	0.0386	CbGeAlD
Fluorouracil—CYP2C9—urine—nephrolithiasis	0.0109	0.0367	CbGeAlD
Fluorouracil—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0483	CcSEcCtD
Fluorouracil—TYMP—Nucleotide metabolism—APRT—nephrolithiasis	0.0101	0.0207	CbGpPWpGaD
Fluorouracil—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.00953	0.0451	CcSEcCtD
Fluorouracil—Stinging—Hydrochlorothiazide—nephrolithiasis	0.00809	0.0383	CcSEcCtD
Fluorouracil—Numbness—Hydrochlorothiazide—nephrolithiasis	0.00791	0.0374	CcSEcCtD
Fluorouracil—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.00757	0.0358	CcSEcCtD
Fluorouracil—SLC22A7—renal system—nephrolithiasis	0.00711	0.0239	CbGeAlD
Fluorouracil—SLC22A7—kidney—nephrolithiasis	0.00687	0.0231	CbGeAlD
Fluorouracil—TYMS—nephron tubule—nephrolithiasis	0.00673	0.0226	CbGeAlD
Fluorouracil—TYMP—cortex of kidney—nephrolithiasis	0.00671	0.0225	CbGeAlD
Fluorouracil—SLC22A7—cortex of kidney—nephrolithiasis	0.00669	0.0225	CbGeAlD
Fluorouracil—ABCC5—nephron tubule—nephrolithiasis	0.00657	0.0221	CbGeAlD
Fluorouracil—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.00625	0.0127	CbGpPWpGaD
Fluorouracil—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00599	0.0283	CcSEcCtD
Fluorouracil—TYMS—cortex of kidney—nephrolithiasis	0.00576	0.0193	CbGeAlD
Fluorouracil—SLC29A1—renal system—nephrolithiasis	0.00549	0.0184	CbGeAlD
Fluorouracil—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00542	0.0256	CcSEcCtD
Fluorouracil—Swelling—Hydrochlorothiazide—nephrolithiasis	0.0054	0.0255	CcSEcCtD
Fluorouracil—SLC29A1—kidney—nephrolithiasis	0.0053	0.0178	CbGeAlD
Fluorouracil—SLC29A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00521	0.0106	CbGpPWpGaD
Fluorouracil—TYMS—Nucleotide metabolism—APRT—nephrolithiasis	0.00519	0.0106	CbGpPWpGaD
Fluorouracil—SLC29A1—cortex of kidney—nephrolithiasis	0.00517	0.0173	CbGeAlD
Fluorouracil—ABCC3—renal system—nephrolithiasis	0.00502	0.0168	CbGeAlD
Fluorouracil—ABCC3—kidney—nephrolithiasis	0.00485	0.0163	CbGeAlD
Fluorouracil—SLC29A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00476	0.0097	CbGpPWpGaD
Fluorouracil—SLC29A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00476	0.0097	CbGpPWpGaD
Fluorouracil—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00476	0.0225	CcSEcCtD
Fluorouracil—ABCC4—nephron tubule—nephrolithiasis	0.00456	0.0153	CbGeAlD
Fluorouracil—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00452	0.00922	CbGpPWpGaD
Fluorouracil—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00448	0.0212	CcSEcCtD
Fluorouracil—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00436	0.0206	CcSEcCtD
Fluorouracil—ABCG2—Iron uptake and transport—ATP6V0A4—nephrolithiasis	0.00425	0.00865	CbGpPWpGaD
Fluorouracil—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00421	0.00857	CbGpPWpGaD
Fluorouracil—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.0042	0.0199	CcSEcCtD
Fluorouracil—ABCC5—Defective B3GAT3 causes JDSSDHD—SLC26A1—nephrolithiasis	0.00415	0.00846	CbGpPWpGaD
Fluorouracil—ABCC4—renal system—nephrolithiasis	0.00414	0.0139	CbGeAlD
Fluorouracil—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00411	0.0195	CcSEcCtD
Fluorouracil—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00401	0.019	CcSEcCtD
Fluorouracil—ABCC4—kidney—nephrolithiasis	0.004	0.0134	CbGeAlD
Fluorouracil—ABCC4—cortex of kidney—nephrolithiasis	0.0039	0.0131	CbGeAlD
Fluorouracil—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00382	0.0181	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00376	0.0178	CcSEcCtD
Fluorouracil—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00369	0.0175	CcSEcCtD
Fluorouracil—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00362	0.0171	CcSEcCtD
Fluorouracil—SLC29A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00361	0.00735	CbGpPWpGaD
Fluorouracil—SLC29A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00361	0.00735	CbGpPWpGaD
Fluorouracil—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0036	0.017	CcSEcCtD
Fluorouracil—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0036	0.017	CcSEcCtD
Fluorouracil—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00357	0.0169	CcSEcCtD
Fluorouracil—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00357	0.0169	CcSEcCtD
Fluorouracil—ABCC5—NRF2 pathway—SLC2A9—nephrolithiasis	0.00353	0.00718	CbGpPWpGaD
Fluorouracil—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00346	0.0164	CcSEcCtD
Fluorouracil—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00344	0.0163	CcSEcCtD
Fluorouracil—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00342	0.0162	CcSEcCtD
Fluorouracil—SLC29A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00335	0.00683	CbGpPWpGaD
Fluorouracil—SLC29A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00335	0.00683	CbGpPWpGaD
Fluorouracil—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0033	0.0156	CcSEcCtD
Fluorouracil—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00328	0.0155	CcSEcCtD
Fluorouracil—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00327	0.0155	CcSEcCtD
Fluorouracil—ABCG2—nephron tubule—nephrolithiasis	0.00322	0.0108	CbGeAlD
Fluorouracil—CYP2C8—renal system—nephrolithiasis	0.00301	0.0101	CbGeAlD
Fluorouracil—SLC29A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00299	0.00609	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00297	0.00605	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00297	0.00605	CbGpPWpGaD
Fluorouracil—SLC22A7—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00297	0.00604	CbGpPWpGaD
Fluorouracil—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00294	0.0139	CcSEcCtD
Fluorouracil—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00291	0.0138	CcSEcCtD
Fluorouracil—CYP2C8—kidney—nephrolithiasis	0.00291	0.00976	CbGeAlD
Fluorouracil—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00287	0.0136	CcSEcCtD
Fluorouracil—CYP1A2—renal system—nephrolithiasis	0.00281	0.00945	CbGeAlD
Fluorouracil—SLC22A7—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00271	0.00553	CbGpPWpGaD
Fluorouracil—SLC22A7—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00271	0.00553	CbGpPWpGaD
Fluorouracil—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.0027	0.0128	CcSEcCtD
Fluorouracil—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00265	0.0125	CcSEcCtD
Fluorouracil—UMPS—Metabolism—GRHPR—nephrolithiasis	0.00265	0.00539	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00265	0.00539	CbGpPWpGaD
Fluorouracil—ABCC3—NRF2 pathway—SLC2A9—nephrolithiasis	0.0026	0.0053	CbGpPWpGaD
Fluorouracil—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00257	0.0121	CcSEcCtD
Fluorouracil—UPP1—Metabolism—GRHPR—nephrolithiasis	0.00246	0.00501	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—GRHPR—nephrolithiasis	0.00246	0.00501	CbGpPWpGaD
Fluorouracil—ABCC4—NRF2 pathway—SLC2A9—nephrolithiasis	0.00244	0.00498	CbGpPWpGaD
Fluorouracil—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00244	0.0115	CcSEcCtD
Fluorouracil—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00244	0.0115	CcSEcCtD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00242	0.00493	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00242	0.00493	CbGpPWpGaD
Fluorouracil—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00241	0.0114	CcSEcCtD
Fluorouracil—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00236	0.0112	CcSEcCtD
Fluorouracil—UMPS—Metabolism—AGXT—nephrolithiasis	0.00236	0.00481	CbGpPWpGaD
Fluorouracil—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00234	0.0111	CcSEcCtD
Fluorouracil—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00234	0.0111	CcSEcCtD
Fluorouracil—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00229	0.0108	CcSEcCtD
Fluorouracil—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00228	0.0108	CcSEcCtD
Fluorouracil—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00223	0.0105	CcSEcCtD
Fluorouracil—ABCC5—Carbohydrate metabolism—SLC26A1—nephrolithiasis	0.00223	0.00454	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—AGXT—nephrolithiasis	0.00219	0.00447	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—AGXT—nephrolithiasis	0.00219	0.00447	CbGpPWpGaD
Fluorouracil—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00219	0.0103	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00213	0.0101	CcSEcCtD
Fluorouracil—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00212	0.01	CcSEcCtD
Fluorouracil—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.0021	0.00994	CcSEcCtD
Fluorouracil—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00209	0.00987	CcSEcCtD
Fluorouracil—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00208	0.00984	CcSEcCtD
Fluorouracil—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00206	0.00974	CcSEcCtD
Fluorouracil—SLC22A7—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00206	0.00419	CbGpPWpGaD
Fluorouracil—SLC22A7—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00206	0.00419	CbGpPWpGaD
Fluorouracil—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00203	0.00962	CcSEcCtD
Fluorouracil—UMPS—Metabolism—APRT—nephrolithiasis	0.00201	0.00409	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—SLC26A1—nephrolithiasis	0.00201	0.00409	CbGpPWpGaD
Fluorouracil—Pain—Hydrochlorothiazide—nephrolithiasis	0.002	0.00946	CcSEcCtD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00197	0.00401	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00197	0.00401	CbGpPWpGaD
Fluorouracil—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00193	0.00912	CcSEcCtD
Fluorouracil—SLC22A7—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00191	0.00389	CbGpPWpGaD
Fluorouracil—SLC22A7—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00191	0.00389	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—APRT—nephrolithiasis	0.00186	0.0038	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—SLC26A1—nephrolithiasis	0.00186	0.0038	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—SLC26A1—nephrolithiasis	0.00186	0.0038	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—APRT—nephrolithiasis	0.00186	0.0038	CbGpPWpGaD
Fluorouracil—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00186	0.00879	CcSEcCtD
Fluorouracil—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00185	0.00875	CcSEcCtD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00183	0.00374	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00183	0.00374	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00175	0.00357	CbGpPWpGaD
Fluorouracil—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00172	0.00815	CcSEcCtD
Fluorouracil—DPYD—Metabolism—GRHPR—nephrolithiasis	0.00171	0.00347	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—GRHPR—nephrolithiasis	0.00171	0.00347	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.0017	0.00347	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.0017	0.00347	CbGpPWpGaD
Fluorouracil—SLC22A7—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.0017	0.00347	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00169	0.00345	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00169	0.00345	CbGpPWpGaD
Fluorouracil—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00166	0.00783	CcSEcCtD
Fluorouracil—CYP2A6—NRF2 pathway—SLC2A9—nephrolithiasis	0.00163	0.00332	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.0016	0.00327	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.0016	0.00327	CbGpPWpGaD
Fluorouracil—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.0016	0.00757	CcSEcCtD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00156	0.00319	CbGpPWpGaD
Fluorouracil—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00155	0.00732	CcSEcCtD
Fluorouracil—DPYD—Metabolism—AGXT—nephrolithiasis	0.00152	0.0031	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—AGXT—nephrolithiasis	0.00152	0.0031	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00152	0.0031	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00152	0.0031	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00151	0.00307	CbGpPWpGaD
Fluorouracil—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00149	0.00704	CcSEcCtD
Fluorouracil—Rash—Hydrochlorothiazide—nephrolithiasis	0.00148	0.00698	CcSEcCtD
Fluorouracil—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00147	0.00697	CcSEcCtD
Fluorouracil—Headache—Hydrochlorothiazide—nephrolithiasis	0.00147	0.00693	CcSEcCtD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00145	0.00295	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00145	0.00295	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—AQP1—nephrolithiasis	0.00143	0.00291	CbGpPWpGaD
Fluorouracil—CYP2A6—Biological oxidations—SLC26A1—nephrolithiasis	0.00143	0.00291	CbGpPWpGaD
Fluorouracil—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00139	0.00657	CcSEcCtD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00138	0.00281	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00138	0.00281	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00136	0.00278	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00136	0.00278	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—AQP1—nephrolithiasis	0.00133	0.00271	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—AQP1—nephrolithiasis	0.00133	0.00271	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—CHRM3—nephrolithiasis	0.00129	0.00263	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—APRT—nephrolithiasis	0.00129	0.00263	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—SLC26A1—nephrolithiasis	0.00129	0.00263	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—APRT—nephrolithiasis	0.00129	0.00263	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—SLC26A1—nephrolithiasis	0.00129	0.00263	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00129	0.00263	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—GRHPR—nephrolithiasis	0.00122	0.00248	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00121	0.00247	CbGpPWpGaD
Fluorouracil—SLC29A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00121	0.00247	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00121	0.00247	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00121	0.00247	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—CHRM3—nephrolithiasis	0.0012	0.00245	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—CHRM3—nephrolithiasis	0.0012	0.00245	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00118	0.00241	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00118	0.00241	CbGpPWpGaD
Fluorouracil—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.00116	0.00236	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00113	0.0023	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00113	0.0023	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00111	0.00226	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00111	0.00226	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—AGXT—nephrolithiasis	0.00108	0.00221	CbGpPWpGaD
Fluorouracil—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00108	0.0022	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00104	0.00213	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00104	0.00213	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00101	0.00205	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00101	0.00205	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000999	0.00204	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000999	0.00204	CbGpPWpGaD
Fluorouracil—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.000989	0.00202	CbGpPWpGaD
Fluorouracil—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.000989	0.00202	CbGpPWpGaD
Fluorouracil—CYP2C8—Biological oxidations—SLC26A1—nephrolithiasis	0.000976	0.00199	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000971	0.00198	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000971	0.00198	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—APRT—nephrolithiasis	0.000921	0.00188	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—SLC26A1—nephrolithiasis	0.000921	0.00188	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—AQP1—nephrolithiasis	0.000921	0.00188	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—AQP1—nephrolithiasis	0.000921	0.00188	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000895	0.00182	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000895	0.00182	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000891	0.00181	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000866	0.00176	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000866	0.00176	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000842	0.00172	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000842	0.00172	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—CHRM3—nephrolithiasis	0.000833	0.0017	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—CHRM3—nephrolithiasis	0.000833	0.0017	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000832	0.0017	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000832	0.0017	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000815	0.00166	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000815	0.00166	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—SLC7A9—nephrolithiasis	0.000806	0.00164	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—DGKH—nephrolithiasis	0.000806	0.00164	CbGpPWpGaD
Fluorouracil—ABCC5—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000805	0.00164	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—GRHPR—nephrolithiasis	0.000802	0.00163	CbGpPWpGaD
Fluorouracil—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.000794	0.00162	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000783	0.00159	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000783	0.00159	CbGpPWpGaD
Fluorouracil—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00075	0.00153	CbGpPWpGaD
Fluorouracil—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00075	0.00153	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000742	0.00151	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000742	0.00151	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—SLC26A1—nephrolithiasis	0.000725	0.00148	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AGXT—nephrolithiasis	0.000714	0.00146	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.000707	0.00144	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—GRHPR—nephrolithiasis	0.000698	0.00142	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000698	0.00142	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000698	0.00142	CbGpPWpGaD
Fluorouracil—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000697	0.00142	CbGpPWpGaD
Fluorouracil—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000697	0.00142	CbGpPWpGaD
Fluorouracil—SLC22A7—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000692	0.00141	CbGpPWpGaD
Fluorouracil—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.000678	0.00138	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—AQP1—nephrolithiasis	0.000656	0.00134	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—ATP6V0A4—nephrolithiasis	0.000647	0.00132	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—SLC26A1—nephrolithiasis	0.000631	0.00129	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AGXT—nephrolithiasis	0.000622	0.00127	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—GRHPR—nephrolithiasis	0.000622	0.00127	CbGpPWpGaD
Fluorouracil—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000621	0.00127	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000617	0.00126	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000617	0.00126	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000617	0.00126	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000617	0.00126	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—APRT—nephrolithiasis	0.000607	0.00124	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—SLC26A1—nephrolithiasis	0.000607	0.00124	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—CHRM3—nephrolithiasis	0.000593	0.00121	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000593	0.00121	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000574	0.00117	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000574	0.00117	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—ATP6V0A4—nephrolithiasis	0.000563	0.00115	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000558	0.00114	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AGXT—nephrolithiasis	0.000554	0.00113	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00055	0.00112	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—APRT—nephrolithiasis	0.000529	0.00108	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—SLC26A1—nephrolithiasis	0.000529	0.00108	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GRHPR—nephrolithiasis	0.000514	0.00105	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000512	0.00104	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000512	0.00104	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000503	0.00102	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000503	0.00102	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—SLC26A1—nephrolithiasis	0.000471	0.00096	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—APRT—nephrolithiasis	0.000471	0.00096	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AGXT—nephrolithiasis	0.000459	0.000934	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AQP1—nephrolithiasis	0.000433	0.000882	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000409	0.000833	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—CHRM3—nephrolithiasis	0.000391	0.000798	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—SLC26A1—nephrolithiasis	0.00039	0.000794	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—APRT—nephrolithiasis	0.00039	0.000794	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000381	0.000776	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000381	0.000776	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AQP1—nephrolithiasis	0.000377	0.000768	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.000365	0.000743	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—DGKH—nephrolithiasis	0.000365	0.000743	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GRHPR—nephrolithiasis	0.000355	0.000723	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000354	0.000722	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000354	0.000722	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—CHRM3—nephrolithiasis	0.000341	0.000694	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AQP1—nephrolithiasis	0.000336	0.000684	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GRHPR—nephrolithiasis	0.000322	0.000657	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AGXT—nephrolithiasis	0.000316	0.000644	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000316	0.000643	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000316	0.000643	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CHRM3—nephrolithiasis	0.000304	0.000618	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AGXT—nephrolithiasis	0.000287	0.000585	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AQP1—nephrolithiasis	0.000278	0.000566	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—APRT—nephrolithiasis	0.000269	0.000548	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—SLC26A1—nephrolithiasis	0.000269	0.000548	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000252	0.000514	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CHRM3—nephrolithiasis	0.000251	0.000512	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—APRT—nephrolithiasis	0.000244	0.000498	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—SLC26A1—nephrolithiasis	0.000244	0.000498	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GRHPR—nephrolithiasis	0.00022	0.000449	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GRHPR—nephrolithiasis	0.000219	0.000446	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AGXT—nephrolithiasis	0.000196	0.0004	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AGXT—nephrolithiasis	0.000195	0.000398	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AQP1—nephrolithiasis	0.000192	0.00039	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000179	0.000365	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AQP1—nephrolithiasis	0.000174	0.000355	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CHRM3—nephrolithiasis	0.000173	0.000353	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SLC26A1—nephrolithiasis	0.000167	0.00034	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—APRT—nephrolithiasis	0.000167	0.00034	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SLC26A1—nephrolithiasis	0.000166	0.000338	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—APRT—nephrolithiasis	0.000166	0.000338	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.00016	0.000325	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CHRM3—nephrolithiasis	0.000157	0.000321	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.000153	0.000312	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.000136	0.000278	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000136	0.000277	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000136	0.000277	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AQP1—nephrolithiasis	0.000119	0.000242	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AQP1—nephrolithiasis	0.000118	0.000241	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	0.000116	0.000236	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—APRT—nephrolithiasis	0.000116	0.000236	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CHRM3—nephrolithiasis	0.000108	0.000219	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CHRM3—nephrolithiasis	0.000107	0.000218	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AQP1—nephrolithiasis	9.67e-05	0.000197	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CHRM3—nephrolithiasis	8.75e-05	0.000178	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AQP1—nephrolithiasis	8.27e-05	0.000168	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CHRM3—nephrolithiasis	7.48e-05	0.000152	CbGpPWpGaD
